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Abstract
Rationale: The lung clearance index is a measure of ventilation
distribution derived from the multiple-breath washout technique.
The lung clearance index is increased in the presence of lower
respiratory tract inflammation and infection in infants with cystic
fibrosis; however, the associations during the preschool years are
unknown.
Objectives:We assessed the ability of the lung clearance index
to detect the presence and extent of lower respiratory tract
inflammation and infection in preschool childrenwith cystic fibrosis.
Methods: Ventilation distribution outcomes were assessed at 82
visits with 58 children with cystic fibrosis and at 38 visits with 31
healthy children aged 3–6 years. Children with cystic fibrosis also
underwent bronchoalveolar lavage fluid collection for detection of
lower respiratory tract inflammation and infection. Associations
between multiple-breath washout indices and the presence and
extent of airway inflammation and infection were assessed using
linear mixed effects models.
Results: Lung clearance index was elevated in children with cystic
fibrosis (mean [SD], 8.00 [1.45]) compared with healthy control
subjects (6.67 [0.56]). In cystic fibrosis, the lung clearance index was
elevated in individuals with lower respiratory tract infections
(difference comparedwithuninfected [95%confidence interval], 0.62
[0.06, 1.18]) and correlated with the extent of airway inflammation.
Conclusions:These data suggest that the lung clearance indexmay
be a useful surveillance tool formonitoring the presence and extent of
lower airway inflammation and infection in preschool children with
cystic fibrosis.
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Pulmonary inflammation and lower
respiratory tract infections are present in the
first months of life in children with cystic
fibrosis (CF), often in the absence of
respiratory symptoms (1). The presence of
inflammatory markers (neutrophils,
neutrophil elastase [NE], IL-8) and
pathogens (including Pseudomonas
aeruginosa and Staphylococcus aureus) in
the lower respiratory tract in early life is
associated with the development and
progression of structural lung disease and
long-term impairments in lung function in
children with CF (2–4). Early surveillance
of lung disease is essential to identifying
and treating respiratory infections,
minimizing pulmonary exacerbations, and
delaying the onset of structural lung
damage and lung function decline.
The lung clearance index (LCI) is a
measure of ventilation distribution derived
from the multiple-breath washout (MBW)
technique. In preschool children with CF,
MBW is easier to perform and more
often abnormal than spirometry or
plethysmography (5). An abnormal LCI
during the preschool years is predictive of
abnormal LCI and spirometry outcomes at
school age (6). In a longitudinal study of
patients with CF aged 6–20 years, LCI was
the first index of lung disease to decline and
the strongest predictor of lung disease
progression (7). In addition, LCI has been
shown to respond to therapeutic
interventions and predict pulmonary
exacerbations in children with CF (8–10).
In the era of newborn screening, LCI has
the potential to be an important clinical
tool for the monitoring of early, often mild
CF lung disease.
Limited data exist on the ability of
MBW to predict the presence of pulmonary
inflammation and infection. During infancy,
LCI correlates with neutrophil count,
IL-8, and pathogen density in
bronchoalveolar lavage (BAL) fluid (11, 12).
In preschool children, LCI is higher in
those with P. aeruginosa detected in the
upper airway (5), but there have been no
studies correlating LCI and lower
respiratory tract inflammation or infections
in this age group. The presence of
bronchiectasis increases dramatically
between the ages of 3 and 6 years in
children with CF; thus, this period
represents a significant window of
opportunity for intervention (4). The aim
of this study was to assess the ability of the
LCI and other markers of ventilation
distribution to detect the presence and
extent of lower respiratory tract
inflammation and infection in preschool
children with CF. Some of the results of
these studies were previously reported in
the form of abstracts (13, 14).
Methods
Study Population
This analysis took place in the setting of an
ongoing longitudinal study between the
Perth and Melbourne centers of the
Australian Respiratory Early Surveillance
Team for Cystic Fibrosis (AREST CF) as
well as Riley Hospital for Children in
Indianapolis, Indiana. Children with CF
were diagnosed following newborn
screening and were enrolled in the AREST
CF early surveillance program at Princess
Margaret Hospital in Perth, Australia, or
Royal Children’s Hospital in Melbourne,
Australia (1). This program starts at
diagnosis (approximately age 3 mo) and
involves annual age-appropriate lung
function testing 2–4 days prior to
performing chest computed tomography
and BAL until the age of 6 years. Healthy
control subjects with no history of
respiratory disease, preterm birth, or
current respiratory symptoms or
medications were also recruited to perform
MBW testing only from the communities in
Perth and Melbourne in Australia and
Indianapolis, Indiana, in the United States.
The ethics committee of each institution
approved the study, and parents
consented to each aspect of the study
separately.
Table 1. Demographics of study population
Cystic Fibrosis Healthy
Control
Subjects
Subjects, n 58 31
Visits, n 82 38
Age, yr 5.16 1.0 5.06 1.0
Sex, male 36 (44%) 18 (47%)
Height z-score 20.046 0.98 0.236 1.24
Weight z-score 0.356 0.86 0.676 1.45
BMI z-score 0.556 0.87 0.776 1.44
FRC, L 0.896 0.22 0.926 0.18
Lung clearance index 8.006 1.45* 6.676 0.56
First-moment ratio, M1/M0 1.736 0.30* 1.526 0.12
Second-moment ratio, M2/M0 6.486 2.44* 4.676 0.79
Current respiratory symptoms 32 of 82 (39%)
Phe508del/Phe508del 35 of 82 (43%)
Phe508del/other 72 of 82 (88%)
Total cell count, 3105/ml 8.136 14.9
Neutrophils, % 23.66 22.5
Neutrophil elastase present 22 of 81 (27%)
Neutrophil elastase, ng/ml 1,0146 2,314
IL-8, pg/ml 3,5576 8,252
Respiratory infection 32 of 81 (39%)
Nonproinflammatory pathogens 4 of 81 (5%)
Proinflammatory pathogens 28 of 81 (35%)
More than one proinflammatory
pathogen
13 of 81 (16%)
Staphylococcus aureus 10 of 81 (12%)
Haemophilus influenzae 9 of 81 (11%)
Pseudomonas aeruginosa 8 of 81 (10%)
Aspergillus spp. 8 of 81 (10%)
Streptococcus pneumoniae 5 of 81 (6%)
Definition of abbreviations: BMI = body mass index; M1/M0 = first-moment ratio; M2/M0 = second-
moment ratio.
Data are presented as mean6 SD or n (%) unless otherwise stated. Height, weight, and BMI z-scores
were calculated using World Health Organization growth standards (23, 24). Current respiratory
symptoms were defined as either parent- or clinician-reported symptoms in the last month.
Respiratory infection was defined as pathogen density greater than 104 cfu/ml, excluding mixed oral flora.
*P, 0.05.
ORIGINAL RESEARCH
Ramsey, Foong, Grdosic, et al.: MBW in Preschool Children with Cystic Fibrosis 1437
Multiple-Breath Washout
MBW was performed using 100% oxygen to
wash out resident nitrogen from the lungs
(EXHALYZER D and SPIROWARE 3.1;
ECO MEDICS AG, Du¨rnten, Switzerland)
using a silicone mouthpiece (15, 16). FRC,
LCI, first-moment ratio (M1/M0), and
second-moment ratio (M2/M0) were
derived from visits with at least two
acceptable measurements with no evidence
of leak or irregular breathing pattern, in line
with current international standards (17).
Two independent, experienced
assessors (K.A.R. and R.E.F.) performed
data quality control using a systematic
approach based on current consensus
statement guidelines (18).
Bronchoalveolar Lavage
A bronchoscopy during which BAL fluid
was collected was performed within 3 days
of MBW testing. The right middle lobe was
lavaged with three aliquots of saline (1 ml/kg
body weight), and an additional aliquot was
lavaged into the lingula or the most affected
lobe identified by computed tomography
(1, 19). The first aliquot of BAL fluid was
processed for the detection of bacteria,
viruses, and fungi using standard culture
techniques. Subsequent aliquots were
pooled for the quantification of pulmonary
inflammation, which included total and
differential cell counts as well as
measurement of free NE activity (lower
limit of detection, 200 ng/ml) (1). An
inflammatory response score was created
by taking a weighted average of the logged
BAL responses: log total cell count per
milliliter of fluid retrieved, log neutrophils
per milliliter of fluid retrieved, log NE, and
log IL-8. The weights of each component
were derived using principal component
analysis. Pulmonary infection was defined
as colony counts for a specific organism
(excluding mixed oral flora) greater
than 104 cfu/ml. Bacterial pathogens known
to elicit a proinflammatory response when
isolated from the lower respiratory tract
(P. aeruginosa, S. aureus, Haemophilus
influenzae, Streptococcus pneumoniae, and
Aspergillus spp.) were described as
proinflammatory pathogens (19).
Respiratory Symptoms
A standardized respiratory symptoms
questionnaire was administered on the
morning of the BAL of children with CF to
gain information on parentally reported
symptoms (cough, upper respiratory tract
infection, sputum production) and current
medication use. A respiratory clinician also
performed a physical examination of the
children and reported the presence or
absence of wheeze, crackles, or respiratory
tract infection. Children were classified as
symptomatic if any symptoms were
reported within the last month.
Statistical Analysis
The upper limits of normal for MBW
indices were calculated from our prospective
healthy control population of children, a
subset of which was previously reported (15).
Associations between MBW indices
and the extent of inflammation and
infection were assessed using linear mixed
effects models with random intercepts for
repeated visits to account for clustering. All
models were adjusted for age at visit and
study center. The coefficients of the fixed
effects of the linear mixed models are
presented with 95% confidence intervals
and P values. These coefficients represent
the adjusted differences between case and
control groups. For example, children with
a respiratory infection had an adjusted
LCI that was 0.62 greater than that of the
children without an infection. The
reference group for all the respiratory
infection subgroups is individuals with no
respiratory infection. Sensitivity and
specificity values were calculated. All
analyses were performed using Stata 13.0
software (StataCorp, College Station, TX).
Table 2. Effect of pulmonary inflammation, infection, and clinical characteristics on
measures of ventilation distribution in preschool children with cystic fibrosis
LCI M1/M0 M2/M0
Clinical characteristics
Respiratory symptoms 20.25 (20.75, 0.25) 0.03 (20.08, 0.13) 20.24 (21.06, 0.59)
Severe genotype 0.18 (21.70, 2.06) 0.16 (20.24, 0.56) 0.29 (22.93, 3.52)
Pulmonary inflammation
Total cell counts 0.25 (0.04, 0.46)* 0.07 (0.03, 0.11)† 0.45 (0.11, 0.79)*
Neutrophil cells 0.10 (20.04, 0.25) 0.03 (0.01, 0.06)* 0.21 (20.03, 0.44)
Presence of neutrophil
elastase
0.58 (20.05, 1.22) 0.15 (0.04, 0.30)† 1.13 (0.10, 2.16)*
Neutrophil elastase
concentration
0.05 (20.08, 0.17) 0.02 (20.01, 0.05) 0.12 (20.08, 0.32)
Inflammatory response
score
0.28 (0.07, 0.49)† 0.07 (0.02, 0.11) † 0.47 (0.11, 0.83)*
Respiratory infection 0.62 (0.06, 1.18)* 0.11 (0.01, 0.23)* 0.78 (20.13, 1.70)
Nonproinflammatory
pathogen
0.53 (20.48, 1.55) 0.18 (20.04, 0.40) 0.78 (20.79, 2.34)
Proinflammatory pathogen 0.65 (0.10, 1.20)* 0.11 (20.01, 0.22) 0.80 (20.08, 1.69)
More than one
proinflammatory
pathogen
1.04 (0.40, 1.68)† 0.18 (0.06, 0.31)† 1.45 (0.45, 2.45)†
Staphylococcus aureus 20.03 (21.11, 1.06) 0.20 (20.01, 0.41) 1.11 (20.59, 2.82)
Haemophilus influenzae 0.23 (20.55, 1.01) 0.02 (20.13,0.18) 20.01 (21.22, 1.21)
Pseudomonas
aeruginosa
0.93 (0.16, 1.71)* 0.07 (20.10, 0.23) 0.69 (20.59, 1.96)
Aspergillus spp. 0.46 (20.41, 1.34) 0.06 (20.11, 0.24) 0.37 (21.01, 1.75)
Streptococcus
pneumoniae
0.71 (20.35, 1.78) 0.16 (20.05, 0.38) 1.24 (20.47, 2.96)
Definition of abbreviations: LCI = lung clearance index; M1/M0 = first-moment ratio; M2/M0 = second-
moment ratio.
Data are presented as mixed model coefficients adjusted for repeated measures and testing center (95%
confidence interval). These coefficients represent the adjusted differences between case and control groups.
For example, children with a respiratory infection had an adjusted LCI that was 0.62 greater than that of
the children without an infection. The reference group for all the respiratory infection subgroups is individuals
with no respiratory infection. Respiratory infection was defined as pathogen density greater than 104 cfu/ml,
excluding mixed oral flora. Proinflammatory pathogens are pathogens known to elicit a proinflammatory
response when isolated from the lower respiratory tract (Pseudomonas aeruginosa, Staphylococcus aureus,
Haemophilus influenzae, Streptococcus pneumoniae, and Aspergillus spp.) (19). The inflammatory response
score was created by taking a weighted average of the logged inflammatory responses: log total cell count
per milliliter of fluid retrieved, log neutrophils per milliliter of fluid retrieved, log neutrophil elastase, and log IL-8.
Bold typeface indicates significant associations with P, 0.05.
*P, 0.05.
†P, 0.01.
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Results
Study Population
Paired ventilation distribution data from
acceptable MBW tests and inflammation
and infection data from BAL fluid were
available for 82 visits with 58 children with
CF. In addition, MBW data was available for
38 visits with 31 healthy control subjects
between 3 and 6 years of age. During the
study period (January 2013 to December
2015), we measured MBW in children
with CF during 104 annual review BAL visits
and in healthy control children at 51 test
visits. Of the 104 test visits of children with
CF, 82 had at least two acceptable MBW
trials (79% feasibility), and of these visits,
56 had at least three acceptable MBW trials
(68%). Of the 51 test visits with healthy
control subjects, 38 had at least two
acceptable MBW trials (75% feasibility), and
of these visits, 25 had at least three acceptable
trials (66%). In this analysis, 24 childrenwithCF
and 7 healthy control subjects contributed
two test visits measured approximately
12 months apart (11.66 2.0 mo).
Upper limits of normal for LCI (7.71),
M1/M0 (1.70), and M2/M0 (5.53) were
calculated on the basis of data derived from
our healthy control population. There were
no differences in age, height, weight, or
FRC between healthy control subjects and
children with CF (P. 0.05) (Table 1). LCI,
M1/M0, and M2/M0 were significantly
higher in children with CF than in healthy
control subjects (Table 1). We found that
55% of preschool children with CF had an
abnormal LCI, 52% had an abnormal
M1/M0, and 64% had an abnormal M2/M0.
Of the 58 children with CF, 88% were
heterozygous for the Phe508del mutation
(Table 1). In the 82 annual surveillance
visits with children with CF, respiratory
symptoms were reported in 39% of visits;
and in BAL fluid samples, NE was
detected in 27%, a respiratory pathogen
was detected in 39%, and a
proinflammatory pathogen was detected in
35%. The most common proinflammatory
pathogen detected was S. aureus (12%),
followed by H. influenzae (11%),
P. aeruginosa (10%), Aspergillus spp. (10%),
and S. pneumoniae (6%).
Clinical Status
There were no differences in MBW
outcomes between individuals with CF with
and without current respiratory symptoms.
In addition, there were no differences
between individuals with mild or severe CF
genotypes (Table 2).
Pulmonary Inflammation
MBW outcomes significantly correlated
with the extent of inflammation in the lower
respiratory tract. LCI, M1/M0, and M2/M0
were positively associated with the total
number of inflammatory cells and the mean
cumulative inflammatory response score
(Table 2). In addition, M1/M0, but not LCI
or M2/M0, was significantly associated with
the percentage of neutrophils (Figure 1).
Both moment ratios, but not LCI, were
significantly higher in children with CF
with detectable free NE activity than in
those without detectable free NE. None of
the MBW indices correlated with the
concentration of NE in the BAL fluid.
MBW outcomes had low sensitivity (38 to
44%) but high specificity (85 to 88%) to
detect free NE in the BAL (Table 3).
Respiratory Infection
LCI and M1/M0, but not M2/M0, were
higher in those with a lower respiratory
tract infection than in those with no
detectable infection (Table 2). LCI was
higher in individuals with a
proinflammatory pathogen detected, but it
was not higher in individuals with a
nonproinflammatory pathogen (Figure 2).
All MBW indices were significantly higher
in individuals with more than one
proinflammatory pathogen detected in the
lower respiratory tract. When the
proinflammatory pathogens were examined
individually, LCI was significantly higher
during visits when P. aeruginosa was
detected in the BAL than in those who were
not infected. There were no significant
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Figure 1. Association between lung clearance index and the extent of neutrophils (top graph) and
total inflammatory cells (bottom graph) in the lower respiratory tract.
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correlations between MBW outcomes and
the presence of other individual pathogens
in the BAL. MBW outcomes had low
sensitivity (45 to 49%) but moderate
specificity (71 to 73%) to detect a significant
respiratory infection (Table 3).
Discussion
The objective of this study was to investigate
whether outcomes of ventilation
distribution measured using the MBW test
were elevated in the presence of lower
respiratory tract inflammation and infection
in preschool children with CF. We report
greater ventilation inhomogeneity in
individuals with CF who had higher
inflammatory cell counts and free NE
detected in the BAL fluid. Children with
detectable pathogens known to elicit a
proinflammatory response in the lung had
higher LCI and moment ratio values than
uninfected children, and P. aeruginosa
infection was individually associated with
higher LCI values. These data suggest that
the LCI and moment ratios derived by
use of the MBW technique may be
important surveillance tools for monitoring
clinical status in preschool children with
CF. Furthermore, these indices could serve
as important outcome measures for clinical
trials of therapies that treat pulmonary
infection and inflammation in young
children with CF.
Limited data exist on the ability of the
MBW technique to predict the presence of
airway inflammation. LCI correlates with
neutrophil and IL-8 concentrations in BAL
fluid in infants with CF (11). However,
longitudinally, there were no associations
between markers of lower respiratory tract
inflammation, such as NE and IL-8
levels, and MBW outcomes over the first
2 years of life (12). To our knowledge, this
is the first study to assess associations
between pulmonary inflammation and
MBW outcomes in preschool children with
CF. We report significant associations
between LCI and the total number of
inflammatory cells detected in the BAL. LCI
was significantly associated with the
inflammatory response score, which
incorporates the primary inflammatory
markers, including total cells, neutrophils,
IL-8, and NE. In addition, the moment
ratios were significantly associated with
total inflammatory cells, neutrophil
cells, and presence of NE. Moment ratios
from the MBW technique describe the
degree of skewness of the nitrogen
washout curve. Increased moment ratios
are thought to represent an increased
release of inert gas toward the end of the
washout and therefore may correlate more
closely with markers of inflammation or
infection in the small peripheral airways of
the lung (20). Neutrophil-dominated
pulmonary inflammation in young children
with CF is one of the earliest signs of lung
disease and is associated with the
development and progression of structural
lung damage, including bronchial wall
thickening and bronchiectasis (2). The
prevalence of structural abnormalities
detected via imaging modalities increases
rapidly during the early preschool years,
and the extent of structural lung disease is
significantly associated with increased LCI
and moment ratios in children with CF
(15, 21). The MBW technique may be an
important tool to monitor the development
of early ventilation defects that may be
caused by inflammation in the lower
airways, and it may be an important
endpoint in therapies designed to prevent
early structural damage.
In this analysis, MBW outcomes were
elevated in young children with a lower
Table 3. Ability of measures of ventilation distribution to detect the presence of
neutrophil elastase and respiratory infections in preschool children with cystic fibrosis
LCI M1/M0 M2/M0
Neutrophil elastase
Sensitivity 41 (26, 57) 44 (29, 60) 38 (25, 54)
Specificity 85 (70, 94) 88 (74, 96) 86 (70, 95)
Respiratory infection
Sensitivity 48 (32, 64) 49 (33, 65) 45 (30, 60)
Specificity 73 (56, 85) 73 (57, 86) 71 (54, 85)
Definition of abbreviations: LCI = lung clearance index; M1/M0 = first-moment ratio; M2/M0 = second-
moment ratio.
Data are presented as percentage (95% confidence interval). Upper limit of normal for LCI = 7.71,
M1/M0 = 1.70, and M2/M0 = 5.53. Respiratory infection was defined as pathogen density greater than
104 cfu/ml, excluding mixed oral flora.
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Figure 2. Lung clearance index in children with cystic fibrosis with and without a lower respiratory
tract infection. Respiratory infection is defined as pathogen density greater than 104 cfu/ml, excluding
mixed oral flora. Proinflammatory pathogens are pathogens known to elicit a proinflammatory
response when isolated from the lower respiratory tract (Pseudomonas aeruginosa, Staphylococcus
aureus, Haemophilus influenzae, Streptococcus pneumoniae, and Aspergillus spp.) (19). Dotted
horizontal line represents the upper limit of normal for lung clearance index = 7.71.
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respiratory tract infection. It was previously
shown that LCI is elevated in young children
with CF who had P. aeruginosa detected
on oropharyngeal swabs in the 6 months
prior to MBW testing (5). LCI was higher
in infants with CF who had P. aeruginosa
detected in BAL fluid (11). In addition, LCI
values were higher in children and
young adults with CF who had chronic
P. aeruginosa infection persistently detected
within the last 6 months (21). In a recent
longitudinal study of 156 children with CF,
researchers reported that children with at
least one positive oral throat swab culture
with S. aureus had higher LCI values than
those without S. aureus (22). We report
that LCI is almost 1 unit higher in
preschool children with CF with detectable
P. aeruginosa in BAL fluid at the time of
MBW testing than in uninfected
children with CF. The presence of any
proinflammatory pathogen known to elicit
a proinflammatory response in the lower
respiratory tract was also associated with
higher LCI values, and detection of more
than one of these pathogens in the BAL was
associated with higher LCI and moment
ratios. Respiratory infections with
proinflammatory pathogens are likely to
cause narrowing, closure, and/or mucus
obstruction in the airways, resulting
in uneven ventilation distribution
throughout the lung and thus higher LCI
values.
A previous study by our group revealed
that infection with a proinflammatory
pathogen resulted in accelerated lung
function decline (increased ventilation
inhomogeneity) during the first 2 years
of life compared with infants who
remained uninfected (12). Longitudinal
studies of preschool children are
required to determine whether transient
increases in LCI above the child’s
individual baseline is indicative
of the presence of a new pulmonary
infection.
Strengths of the present study are the
use of BAL fluid for the assessment of
lower respiratory tract inflammation and
infection and that clinical BAL data and
MBW outcomes were assessed within the
same week. Furthermore, we prospectively
recruited healthy children from the local
community to provide control reference
MBW data. Limitations of the study are that
children with CF underwent annual
surveillance, so we do not have access to
lower airway inflammation and infection
data in the time between annual visits. In
addition, children with CF in this study
were deemed well enough to receive a
general anesthetic and were clinically
stable at the time of the MBW testing.
Therefore, we are unable to comment on
whether MBW outcomes were altered in
individuals with moderate or severe
respiratory symptoms. We also do not yet
have sufficient numbers in our cohort to
perform longitudinal analyses of the
changes in MBW over time with clinical
status.
Our findings support the notion that
the MBW technique is an important
surveillance tool in the monitoring of early
lung disease in young children with CF.
Global measures of ventilation distribution
were associated with the presence and
extent of pulmonary inflammation and
infection in the lower respiratory tract at
the time of MBW testing. These data
provide further evidence that outcomes
obtained with the MBW technique can
reflect mild, heterogeneous, early changes in
the lung caused by the development of
early CF lung disease. Further longitudinal
studies are required to confirm these results
and determine the ability of MBWoutcomes
to detect changes in disease status in
early life. Our results support further
development and validation of the MBW
technique to serve as an important
noninvasive tool for monitoring early
manifestations of CF lung disease as well as
an endpoint in therapeutic trials aimed
at reducing the development of
irreversible structural disease in young
children with CF. n
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